IP Library Granted Patent US 11,285,284
Granted Patent B2
US 11,285,284 · App. 16/098,800 · Granted Mar 29, 2022

Methods for treatment of pulmonary lung diseases with improved therapeutic efficacy and improved dose efficiency

Inventors: Louis Thomas Germinario (Kingsport, TN); John H. Hebrank (Durham, NC); Charles Eric Hunter (Boone, NC); Thomas P. Stern (Huntersville, NC)
Assignee: Pneuma Respiratory, Inc.
A61M16/024A61B5/082A61B5/087A61M11/003A61M11/005A61M15/0021A61M15/0085A61M15/0091A61M15/025A61M16/0051A61M16/0066A61M16/021A61M16/107A61M16/108A61M16/142G16H50/20G16H50/30A61B5/0816A61B5/091A61M15/00A61M16/022A61M16/10A61M16/1075A61M2016/0018A61M2016/0021A61M2016/0027A61M2016/0036A61M2016/0039A61M2205/0294A61M2205/33A61M2205/3306A61M2205/3327A61M2205/3331A61M2205/3553A61M2205/3569A61M2205/3584A61M2205/3592A61M2205/502A61M2205/584A61M2205/587A61M2205/7536A61M2206/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,285,284
App. No.
16/098,800
Granted
Mar 29, 2022
Kind
B2
Abstract

A droplet delivery device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The droplet delivery device includes a housing, a reservoir, and ejector mechanism, and at least one differential pressure sensor. The droplet delivery device is automatically breath actuated by the user when the differential pressure sensor senses a predetermined pressure change within housing. The droplet delivery device is then actuated to generate a stream of droplets having an average ejected droplet diameter within the respirable size range, e.g, less than about 5 μm, so as to target the pulmonary system of the user.

Claims (37)

1. A method for delivering a therapeutic agent as an ejected stream of droplets generated via a piezoelectric actuated droplet delivery device in a respirable range to the pulmonary system of a subject for the treatment of a pulmonary disease, disorder or condition, the method comprising:

(a) generating the ejected stream of droplets via the piezoelectric actuated droplet delivery device, wherein at least about 70% of the ejected stream of droplets have an average ejected droplet diameter of less than about 5 μm; and

(b) delivering the ejected stream of droplets to the pulmonary system of the subject such that at least about 70% of the mass of the ejected stream of droplets is delivered to the pulmonary system of the subject during use to thereby treat the pulmonary disease, disorder or condition;

wherein the piezoelectric actuated droplet delivery device comprises:

a housing comprising a mouthpiece located at an airflow exit of the housing, and an airflow inlet flow element positioned at an airflow entrance of the housing;

a fluid ampoule disposed within or in fluid communication with the housing comprising a fluid reservoir for receiving a volume of fluid comprising the therapeutic agent;

an electronically actuated ejector mechanism in fluid communication with the fluid ampoule and configured to generate the ejected stream of droplets;

at least one differential pressure sensor positioned within the housing, the at least one differential pressure sensor configured to activate the ejector mechanism upon sensing a pre-determined pressure change within the housing to thereby generate the ejected stream of droplets;

the ejector mechanism comprising a piezoelectric actuator and an aperture plate, the aperture plate having a plurality of openings formed through its thickness and the piezoelectric actuator operable to oscillate the aperture plate at a frequency to thereby generate the ejected stream of droplets;

wherein the housing, airflow inlet flow element, and mouthpiece are configured to facilitate non-turbulent airflow across an exit side of the aperture plate and to provide sufficient non-turbulent airflow through the device during use.

2. The method of claim 1 , wherein the pulmonary disease, disorder or condition is selected from asthma, chronic obstructive pulmonary diseases (COPD) cystic fibrosis (CF), tuberculosis, chronic bronchitis, and pneumonia.

3. The method of claim 1 , wherein the therapeutic agent is a COPD medication, an asthma medication, or an antibiotic.

4. The method of claim 1 , wherein the therapeutic agent is selected from albuterol sulfate, ipratropium bromide, tobramycin, and combinations thereof.

5. The method of claim 1 , wherein the therapeutic agent is delivered to the pulmonary system of the subject at a reduced dosage, as compared to standard propellant based inhaler dosages.

6. The method of claim 1 , wherein the ejected stream of droplets are subjected to an approximate 90 degree change of trajectory within the piezoelectric actuated droplet delivery device such that droplets having a diameter greater than about 5 μm are filtered from the ejected stream of droplets due to inertial forces, without being carried in entrained airflow through and out of the piezoelectric actuated droplet delivery device to the pulmonary system of the subject.

7. The method of claim 1 , wherein the ejected stream of droplets is delivered over a period of time less than about 2 seconds.

8. The method of claim 1 , wherein the aperture plate of the piezoelectric actuated droplet delivery device comprises a domed shape.

9. A method of treating COPD in a subject in need thereof, the method comprising:

(a) generating an ejected stream of droplets comprising a therapeutic agent for the treatment of COPD via a piezoelectric actuated droplet delivery device, wherein at least about 70% of the ejected stream of droplets have an average ejected droplet diameter of less than about 5 μm; and

(b) delivering the ejected stream of droplets to the pulmonary system of the subject such that at least about 70% of the mass of the ejected stream of droplets is delivered to the pulmonary system of the subject during use to thereby treat COPD;

wherein the piezoelectric actuated droplet delivery device comprises:

a housing comprising a mouthpiece located at an airflow exit of the housing, and an airflow inlet flow element positioned at an airflow entrance of the housing;

a fluid ampoule disposed within or in fluid communication with the housing comprising a fluid reservoir for receiving a volume of fluid comprising the therapeutic agent;

an electronically actuated ejector mechanism in fluid communication with the fluid ampoule and configured to generate the ejected stream of droplets;

at least one differential pressure sensor positioned within the housing, the at least one differential pressure sensor configured to activate the ejector mechanism upon sensing a pre-determined pressure change within the housing to thereby generate the ejected stream of droplets;

the ejector mechanism comprising a piezoelectric actuator and an aperture plate, the aperture plate having a plurality of openings formed through its thickness and the piezoelectric actuator operable to oscillate the aperture plate at a frequency to thereby generate the ejected stream of droplets;

wherein the housing, airflow inlet flow element, and mouthpiece are configured to facilitate non-turbulent airflow across an exit side of the aperture plate and to provide sufficient non-turbulent airflow through the device during use.

10. A method of treating asthma in a subject in need thereof, the method comprising:

(a) generating an ejected stream of droplets comprising a therapeutic agent for the treatment of asthma via a piezoelectric actuated droplet delivery device, wherein at least about 70% of the ejected stream of droplets have an average ejected droplet diameter of less than about 5 μm; and

(b) delivering the ejected stream of droplets to the pulmonary system of the subject such that at least about 70% of the mass of the ejected stream of droplets is delivered to the pulmonary system of the subject during use to thereby treat asthma;

wherein the piezoelectric actuated droplet delivery device comprises:

a housing comprising a mouthpiece located at an airflow exit of the housing, and an airflow inlet flow element positioned at an airflow entrance of the housing;

a fluid ampoule disposed within or in fluid communication with the housing comprising a fluid reservoir for receiving a volume of fluid comprising the therapeutic agent;

an electronically actuated ejector mechanism in fluid communication with the fluid ampoule and configured to generate the ejected stream of droplets;

at least one differential pressure sensor positioned within the housing, the at least one differential pressure sensor configured to activate the ejector mechanism upon sensing a pre-determined pressure change within the housing to thereby generate the ejected stream of droplets;

the ejector mechanism comprising a piezoelectric actuator and an aperture plate, the aperture plate having a plurality of openings formed through its thickness and the piezoelectric actuator operable to oscillate the aperture plate at a frequency to thereby generate the ejected stream of droplets;

wherein the housing, airflow inlet flow element, and mouthpiece are configured to facilitate non-turbulent airflow across an exit side of the aperture plate and to provide sufficient non-turbulent airflow through the device during use.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2019
From: GERMINARIO, LOUIS THOMAS; HEBRANK, JOHN H.; HUNTER, CHARLES ERIC; STERN, THOMAS P.
To: PNEUMA RESPIRATORY, INC.
Reel/Frame 050030/0415 →
Continuity (11)
Provisional Application 62471929 · Mar 15, 2017
Provisional Application 62448796 · Jan 20, 2017
Provisional Application 62428696 · Dec 1, 2016
Provisional Application 62422932 · Nov 16, 2016
Provisional Application 62416026 · Nov 1, 2016
Provisional Application 62399091 · Sep 23, 2016
Provisional Application 62354437 · Jun 24, 2016
Provisional Application 62334076 · May 10, 2016
Provisional Application 62332352 · May 5, 2016
Provisional Application 62331328 · May 3, 2016
Related Publication 20190125985A1 · May 2, 2019
Cited By (11)
US 12,279,650 US 12,471,625 US 12,484,618 US 12,491,324 US 12,501,929 US 12,521,498 US 12,564,690 US 12,569,627 US 12,708,724 US 12,714,804 US 12,734,312